Primary Dysautonomias
8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Nervous System Diseases
Narrower: Dysautonomia, Familial 1, Multiple System Atrophy 4
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| CUE1 non-invasive device for multiple system atrophy | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexmedetomidine hydrochloride for dysautonomia, familial | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Epidural spinal cord stimulation for primary dysautonomias | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Epidural Spinal Cord Stimulation System for primary dysautonomias | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| NightWare for primary dysautonomias | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| PBT-434 for multiple system atrophy | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| TEV-56286 for multiple system atrophy | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| YA-101 for multiple system atrophy | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.